The Metabolic Syndrome – What is the Value of its identification?

Anne Till

Abstract


The identification of the Metabolic Syndrome (MS) has been under discussion and intense investigation since 1998. Only recently does it appear that consensus is being reached between different organizations regarding itsidentification. Nonetheless, the true value in identifying the MS remains under question, as does the debate around its existence . The real value in identifying the MS may simply be the ability to identify individuals at increased risk for developing cardiovascular disease (CVD) and diabetes. Further identification of abnormalities associated with the MS should encourage practitioners to investigate and search for other risk factors associated with CVD and diabetes. Part of the problem in identifying and treating the MS is that the cause of associated abnormalities remains unclear. However current research seems to indicate that oxidative stress and inflammation may play a pivotal role in the development of insulin resistance (IR) and the MS. Regardless of the usefulness of indentifying the MS and its contributing causes, certain take home messages for practitioners remain the same, including emphasis on the importance of weight loss in overweight patients, the role of regular exercise and diet quality, with a new emphasis on the role of an adequate micronutrient intake and specifically nutrients with antioxidant properties.

Full Text: PDF



The South African Journal of Clinical Nutrition (SAJCN) is peer reviewed and an approved South African journal for the measurement of research output of public higher education institutions (Department of Education (DE) accredited).

SAJCN is proudly published by Medpharm Publications (Pty) Ltd, PO Box 14804, Lyttelton, 0157, RSA, Tel: +27 12 664 7460, Fax: +27 12 664 6276, Website: www.medpharm.co.za

This journal is hosted by: OpenJournals Publishing. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License